Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
May’s Brexit plan cautiously welcomed by biopharma sector
Our industry’s priority throughout these negotiations is to ensure patients in both the UK and EU can continue to access the medicine and vaccines they need.”.
Latest news
-
GSK sells eczema and psoriasis drug to Dermavant for £250m
GSK’s tighter focus on respiratory, HIV, oncology, and vaccines has already seen it cull 30 pipeline programmes and offload its rare disease assets to Orchard Therapeutics.
-
New ABPI president pledges closer collaboration with NHS
Nordkamp says his main priorities will be to work together with the NHS to transform patient care through improved access to new drugs and vaccines, and making sure that Britain maintains
-
Malthus’ orphans
This latter category includes many orphan drugs and rare diseases, whose health economic outcomes are often much less than other parts of the market, such as antibiotics or vaccines, for example.
-
Alcon spin-off prompts Novartis downgrade by Moody’s
spanning innovative medicines, generics, vaccines, consumer health and veterinary medicines. ... Vasella’s successors at the helm of Novartis - Joe Jimenez and latterly Vas Narasimhan – have followed that path, dumping vaccines, veterinary and
-
Incisive Health and 90TEN take home Integrated Communications awards
Focusing on improving vaccine uptake, the winning work titled ‘Break the Flu Cycle’and aimed to change vaccination practices and behaviours among healthcare professionals. ... the vaccine of choice for all adults aged 65 years and over for the
More from news
Approximately 106 fully matching, plus 1,027 partially matching documents found.
Latest Intelligence
-
Advancing women in healthcare
She joined Merck &Co in 2009 and sees her role in promoting vaccines and facilitating greater access to them in all parts of the world as an extension of this same ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s Health at MSD.
-
Uncertainty, austerity and Brexit
Newer plans to lower the QALY for vaccines to £15, 000 should alarm all companies, as it suggests that the QALY for all medicines could also be lowered. ... This is essential. Vaccines are an interesting case study for the post-Brexit world.
-
Health on instalment
The only apt parallel might be the discovery of antibiotics or vaccines, but even those milestones may end up paling in comparison.
-
Deal Watch January 2018
Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales of GSK's QS-21 containing vaccines. ... In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.
-
The good, the bad and the ugly
This was driven largely by higher-than-expected sales of its pneumonia vaccine, Prevnar, which accounted for more than 11% of its total revenues in the third quarter of 2017.
More from intelligence
Approximately 5 fully matching, plus 74 partially matching documents found.
Latest appointments
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
Prior to Sobi, O’Brien spent seven years working at Novartis for its vaccines arm and then with the Novartis Institute for Biomedical Research (NIBR), where she worked closely with the
More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Infographic: The vaccine opportunity in Asia
Infographic: The vaccine opportunity in Asia. As predicted, the vaccine market in emerging and developing countries has continued to expand. ... Download our latest infographic in which we explore the vaccine opportunity in Asia.
-
Case Study: Private market opportunity for a travel vaccine
Case Study: Private market opportunity for a travel vaccine. Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. ... travel. Who the key stakeholders were in each market, in terms of
-
Exploring the Opportunity For Halal In Healthcare
As pork is forbidden by Islam, the use of pork-based gelatin in many vaccines has resulted in considerable resistance to vaccination among the Islamic community. ... Data has demonstrated a decrease in immunization rates in majority Muslim countries such
-
emotive. expands Medical Writing and Client Services teams
Working for a number of award-winning agencies, he has broad experience across multiple therapy areas including diabetes, haematology, immunology, iron deficiency, oncology and vaccines.
-
emotive Account Management team boosted following recent pitch wins
Following a series of recent pitch wins spanning e-learning, medical education, disease awareness and consumer facing websites for clients such as Novartis Vaccines, VirginCare, Novo Nordisk and Takeda, emotive have
More from PMHub
Approximately 5 fully matching, plus 25 partially matching documents found.
Featured jobs
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Roche keeps Venclexta train rolling with new leukaemia filing
- NHS England says yes to Roche's Hemlibra
- Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices
- Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
- Brexit rebels win vote on European Medicines Agency alignment
- Data Visualisation
- The True Potential of Mobile Health Tech
- NHS England to Vertex: come clean on Orkambi offer
- Novartis follows Pfizer and freezes US prices this year
PMHub
OPEN Access Consulting
OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
